An Oasis founding member is stepping away from the band's highly-anticipated reunion tour following a prostate cancer ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

Paul "Bonehead" Arthurs, the longtime guitarist for and founding member of Oasis, is stepping away from the band's current ...

An international study reports that the combination of two drugs could significantly retard the development of a dangerous ...

We have covered more than a few cancers in our “I Screen, You Screen” series, so we know that cancer starts as an abnormal ...

Corayer has used his platform, and his cancer fight, to push more men to talk to their doctors about prostate cancer.

Now that Prostate Cancer Awareness Month has ended, Mercy Health is urging men to take a closer look at what they really know ...

Niraparib is a “maintenance” drug approved to keep certain types of cancer from coming back, including ovarian cancer, ...

PET can guide intensified salvage therapy in prostate cancer and help reduce the risk for treatment failure, new research suggests.

Advances in prostate cancer early detection and treatment have improved outcomes in men diagnosed with the disease.

Prostate Cancer Foundation of Australia (PCFA) and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group ...

The median follow-up of 37 months showed that PSMAiSRT improved FFS and eugonadal FFS, with significant improvements in the ...